Positive Health Online
Your Country
![[Image: http://www.abundanceandhealth.co.uk]](/img/original/BannerAvatar/2836.df7d2315253110ff5b3a566f94871f99.jpg "http://www.abundanceandhealth.co.uk")
![[Image: https://www.water-for-health.co.uk/]](/img/original/BannerAvatar/4046.12831f50177f8848ee87b8e94411d6b3.jpg "https://www.water-for-health.co.uk/")
![[Image: http://www.balens.co.uk]](/img/original/BannerAvatar/2148.50367fa908013fae0a7f1a171543ef92.jpg "http://www.balens.co.uk")
![[Image: http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer]](/img/original/BannerAvatar/1859.1296090fd8385e7ceff51c8011559097.jpg "http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer")
Research: CHEUNG, Department of
Listed in Issue 47
Abstract
CHEUNG, Department of Surgery, The University of Hong Kong, Queen Mary Hospital and Tung Wah Hospital. Mszklc@msnl.surgery.nottingham.ac.uk write that in most Western countries, gamolenic acid is the first-line treatment for women with cyclical mastalgia (breast pain) . The author carried out a prospective study to study the efficacy of gamolenic acid provided in evening primrose oil to treat mastalgia .
Background
Methodology
66 women from a breast referral clinic from the Department of Surgery, University of Hong Kong, recruited for the prospective study, completed an anonymous questionnaires, seen by a breast surgeon and were followed up with a breast pain diary. Gamolenic acid was provided in evening primrose oil from Efamast, Scotia Pharmaceuticals Ltd, Scotia House, Stirling, Scotland).
Results
34 women had persistently disturbing mastalgia and were started on Efamast. Responses were measured at 3 and 6 months. An overall useful response rate of 97% was seen at 6 months. Side effects occurred in 12% of women, but were insignificant.
Conclusion
Efamast may be recommended as a first-line specific treatment for these women with disturbing cyclical mastalgia.
References
Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. The Australian and New Zealand Journal of Surgery 69(7): 492-4. Jul 1999.
